These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 36276653)

  • 1. Advancing
    Wuensche TE; Stergiou N; Mes I; Verlaan M; Schreurs M; Kooijman EJM; Janssen B; Windhorst AD; Jensen A; Asuni AA; Bang-Andersen B; Beaino W; Dongen GAMS; Vugts DJ
    Theranostics; 2022; 12(16):7067-7079. PubMed ID: 36276653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of
    Stergiou N; Wuensche TE; Schreurs M; Mes I; Verlaan M; Kooijman EJM; Windhorst AD; Helboe L; Vergo S; Christensen S; Asuni AA; Jensen A; Van Dongen GAMS; Bang-Andersen B; Vugts DJ; Beaino W
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1306-1317. PubMed ID: 36635462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the Impact of the H310A FcRn Region Mutation on
    Wuensche TE; Stergiou N; Mes I; Verlaan M; Kooijman EJM; Windhorst AD; Jensen A; Asuni AA; Bang-Andersen B; van Dongen GAMS; Vugts DJ; Beaino W
    Mol Imaging Biol; 2024 Oct; 26(5):823-834. PubMed ID: 39093482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
    Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specifically labeled
    Kristensen LK; Christensen C; Jensen MM; Agnew BJ; Schjöth-Frydendahl C; Kjaer A; Nielsen CH
    Theranostics; 2019; 9(15):4409-4420. PubMed ID: 31285769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical
    Chomet M; Schreurs M; Bolijn MJ; Verlaan M; Beaino W; Brown K; Poot AJ; Windhorst AD; Gill H; Marik J; Williams S; Cowell J; Gasser G; Mindt TL; van Dongen GAMS; Vugts DJ
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):694-707. PubMed ID: 32889615
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Price EW; Carnazza KE; Carlin SD; Cho A; Edwards KJ; Sevak KK; Glaser JM; de Stanchina E; Janjigian YY; Lewis JS
    J Nucl Med; 2017 Sep; 58(9):1386-1394. PubMed ID: 28280216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-Induced Radiosynthesis of
    Klingler S; Fay R; Holland JP
    J Nucl Med; 2020 Jul; 61(7):1072-1078. PubMed ID: 31924725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DFO-Km: A Modular Chelator as a New Chemical Tool for the Construction of Zirconium-89-Based Radiopharmaceuticals.
    Salih AK; Dominguez Garcia M; Raheem SJ; Ahiahonu WK; Price EW
    Inorg Chem; 2023 Dec; 62(50):20806-20819. PubMed ID: 37751491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4
    Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
    Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total-Body PET and Highly Stable Chelators Together Enable Meaningful
    Berg E; Gill H; Marik J; Ogasawara A; Williams S; van Dongen G; Vugts D; Cherry SR; Tarantal AF
    J Nucl Med; 2020 Mar; 61(3):453-460. PubMed ID: 31562219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas.
    Bhattacharyya S; Kurdziel K; Wei L; Riffle L; Kaur G; Hill GC; Jacobs PM; Tatum JL; Doroshow JH; Kalen JD
    Nucl Med Biol; 2013 May; 40(4):451-7. PubMed ID: 23454247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Routine
    Wuensche TE; Nauta S; van Dongen GAMS; Vugts DJ
    J Labelled Comp Radiopharm; 2024 Jun; 67(8):280-287. PubMed ID: 38744538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer.
    Parent EE; Gleba JJ; Knight JA; Kenderian SJ; Copland JA; Cai H
    Mol Imaging Biol; 2024 Oct; 26(5):847-857. PubMed ID: 39174789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm.
    Suurs FV; Lorenczewski G; Stienen S; Friedrich M; de Vries EGE; de Groot DJA; Lub-de Hooge MN
    J Nucl Med; 2020 Nov; 61(11):1594-1601. PubMed ID: 32284393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain.
    Fang XT; Hultqvist G; Meier SR; Antoni G; Sehlin D; Syvänen S
    Neuroimage; 2019 Jan; 184():881-888. PubMed ID: 30300753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Chelator-to-Antibody Ratio on Development of
    Tsai SC; Farn SS; Lo WL; Ou Yang FY; Kang YC; Chen LC; Chen KT; Liao JW; Kung JY; Chen JT; Huang FJ
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138961
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a Specifically Labeled
    Zheng M; Liu Q; Zhang H; Wang Y; Zhang K; Mu H; Fu F; Zhang X; Wang Y; Miao L
    Mol Pharm; 2024 Oct; 21(10):5205-5216. PubMed ID: 39322604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging.
    Syvänen S; Fang XT; Hultqvist G; Meier SR; Lannfelt L; Sehlin D
    Neuroimage; 2017 Mar; 148():55-63. PubMed ID: 28069541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.